Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $87.83 -0.66%
Revenue Growth %: +9.8%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +9.8%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) said to see fourth-quarter sales growth in the low-to-mid single-digit range. Comments were made on the company's conference call this morning following
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- MP Materials seen largely insulated after China export-control move
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
